These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 13704239)

  • 1. [The content of copper in the blood serum in normal subjects and in patients with various diseases of the brain].
    GEKHT BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1961; 61():707-12. PubMed ID: 13704239
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of copper in serum and urine of hepatolenticular degeneration patient and their clinic meaning].
    Deng SL; Li XF; Guo XL
    Guang Pu Xue Yu Guang Pu Fen Xi; 2003 Jun; 23(3):576-8. PubMed ID: 12953546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution to the data on copper concentration in blood and urine in patients with Wilson's disease and in normal subjects.
    Lech T; Sadlik JK
    Biol Trace Elem Res; 2007 Jul; 118(1):16-20. PubMed ID: 17848726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of free copper ion concentrations in blood serum using T(1) relaxation rates.
    Blicharska B; Witek M; Fornal M; Mackay AL
    J Magn Reson; 2008 Sep; 194(1):41-5. PubMed ID: 18556226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors influencing serum ceruloplasmin levels in normal individuals.
    Cox DW
    J Lab Clin Med; 1966 Dec; 68(6):893-904. PubMed ID: 5926186
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the serum copper-oxidase activity in 8 families affected by Struempell-Wilson disease (hepatolentricular degeneration)].
    GIAGHEDDU M; CHESS-PERLE E
    Sist Nerv; 1961; 13():237-52. PubMed ID: 13898276
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatolenticular degeneration and pregnancy].
    Tsuzuki E; Scaff M; Roitman I; Neme B; Canelas HM
    Rev Hosp Clin Fac Med Sao Paulo; 1976; 31(1):35-8. PubMed ID: 1257671
    [No Abstract]   [Full Text] [Related]  

  • 9. A study on the concentrations of serum zinc, non-ceruloplasmin copper, reactive oxygen and nitrogen species in children with Wilson's disease.
    Geetha A; Jeyachristy SA; Selvamathy SM; Ilavarasi S; Surendran R
    Clin Chim Acta; 2007 Aug; 383(1-2):165-7. PubMed ID: 17573059
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fatty liver hepatitis].
    Seidler D
    Dtsch Med Wochenschr; 1997 Jun; 122(24):802-3. PubMed ID: 9229566
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fluctuating blood copper concentrations].
    Köbberling J
    Dtsch Med Wochenschr; 1995 Mar; 120(13):461-2. PubMed ID: 7712938
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of some estrogens on the serum copper content, especially in Wilson's disease].
    PLOOIJ M; van der MEER ; KAAG A
    Ned Tijdschr Geneeskd; 1961 Mar; 105():471-6. PubMed ID: 13736377
    [No Abstract]   [Full Text] [Related]  

  • 13. [Copper: interpretation of the test results].
    Shimizu M
    Nihon Rinsho; 1969 Mar; ():Suppl:891-8. PubMed ID: 5408772
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatolenticular degeneration complicated with acute hematolysis and acute liver failure: report of one case].
    Xu CR; Yang Z; Rao RC
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1160, 1168. PubMed ID: 14669749
    [No Abstract]   [Full Text] [Related]  

  • 15. [The content of copper in the tissues of the brain in normal conditions and in various diseases of the nervous system].
    GEKHT BM
    Biull Eksp Biol Med; 1961 Feb; 51():49-54. PubMed ID: 13704240
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct measurement of free copper in serum or plasma ultrafiltrate.
    McMillin GA; Travis JJ; Hunt JW
    Am J Clin Pathol; 2009 Feb; 131(2):160-5. PubMed ID: 19141375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of copper determination in late onset of Wilson's disease.
    Lech T; Hydzik P; Kosowski B
    Clin Toxicol (Phila); 2007 Sep; 45(6):688-94. PubMed ID: 17849244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Movement disorder associated with abnormal copper metabolism and decreased blood antioxidants.
    Pall HS; Williams AC; Blake DR; Winyard P; Chirico S; Brailsford S
    J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1234-5. PubMed ID: 3668575
    [No Abstract]   [Full Text] [Related]  

  • 19. Is low serum tocopherol in Wilson's disease a significant symptom?
    Sinha S; Christopher R; Arunodaya GR; Prashanth LK; Gopinath G; Swamy HS; Taly AB
    J Neurol Sci; 2005 Feb; 228(2):121-3. PubMed ID: 15694191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ultrafiltration and solid phase extraction for the separation of free and protein-bound serum copper for the Wilson's disease diagnosis.
    Bohrer D; Do Nascimento PC; Ramirez AG; Mendonça JK; De Carvalho LM; Pomblum SC
    Clin Chim Acta; 2004 Jul; 345(1-2):113-21. PubMed ID: 15193985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.